High Pathologic Complete Response Rates of BRCA1-Positive Breast Cancers after Neoadjuvant Chemotherapy with Cisplatin

被引：0
|
作者：
Hof, Holger
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 465
页数：3
相关论文
共 50 条
  • [41] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    Tanioka, M.
    Shimizu, C.
    Yonemori, K.
    Yoshimura, K.
    Tamura, K.
    Kouno, T.
    Ando, M.
    Katsumata, N.
    Tsuda, H.
    Kinoshita, T.
    Fujiwara, Y.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 297 - 302
  • [42] MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer
    Sener, Stephen F.
    Sargent, Rachel E.
    Lee, Connie
    Manchandia, Tejas
    Le-Tran, Vivian
    Olimpiadi, Yuliya
    Zaremba, Nicole
    Alabd, Andrew
    Nelson, Maria
    Lang, Julie E.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (06) : 903 - 910
  • [43] Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?
    Fushimi, Atsushi
    Kudo, Rei
    Takeyama, Hiroshi
    CLINICAL BREAST CANCER, 2020, 20 (01) : E82 - E88
  • [44] Predictors of Axillary Pathologic Complete Response Following Neoadjuvant Chemotherapy for Node Positive Breast Cancer
    Kaur, Ishapreet
    Zaborowski, Alexandra
    Prichard, Ruth
    O'Connell, Lauren
    McNally, S.
    Quinn, S.
    Walshe, J.
    Rothwell, J.
    Geraghty, James
    Evoy, Denis
    McCartan, Damien
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S33 - S33
  • [45] Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
    Nikolai Havn Sæther
    Elina Skuja
    Arvids Irmejs
    Jelena Maksimenko
    Edvins Miklasevics
    Gunta Purkalne
    Janis Gardovskis
    Hereditary Cancer in Clinical Practice, 16
  • [46] Cliniopathologic Features in Predicting Complete Pathologic Response (pCR) after Neoadjuvant Herceptin Chemotherapy in HER2+Breast Cancers
    Ding, Qingqing
    Mittendorf, Elizabeth A.
    Lyons, Genevieve R.
    Bassett, Roland L.
    Hunt, Kelly K.
    Sahin, Aysegul A.
    Wu, Yun
    LABORATORY INVESTIGATION, 2016, 96 : 40A - 40A
  • [47] Cliniopathologic Features in Predicting Complete Pathologic Response (pCR) after Neoadjuvant Herceptin Chemotherapy in HER2+Breast Cancers
    Ding, Qingqing
    Mittendoof, Elizabeth A.
    Lyons, Genevieve R.
    Bassett, Roland L.
    Hunt, Kelly K.
    Sahin, Aysegul A.
    Wu, Yun
    MODERN PATHOLOGY, 2016, 29 : 40A - 40A
  • [48] Triple Positive Breast Cancers Treated with Neoadjuvant Therapy - Clinicopathologic Characteristics and Pathologic Complete Response Rate
    Kandel, Avi
    Kombak, Faruk
    Campanella, Gabriele
    Bilal, Khawaja
    Kowtha, Lakshmi
    Collins, Victoria
    Zeizafoun, Nebras
    Henderson, Gregory
    Harigopal, Malini
    Zeng, Jennifer
    LABORATORY INVESTIGATION, 2024, 104 (03) : S183 - S184
  • [49] BRCA pathogenic variants in luminal B breast cancer: A game changer for pathologic complete response in neoadjuvant chemotherapy?
    Di Leone, A.
    Castagnetta, V.
    Di Guglielmo, E.
    Accetta, C.
    Carnassale, B.
    D'Archi, S.
    De Lauretis, F.
    Franco, A.
    Gagliardi, F.
    Magno, S.
    Moschella, F.
    Natale, M.
    Sanchez, A. M.
    Scardina, L.
    Silenzi, M.
    Masetti, R.
    Franceschini, G.
    BREAST, 2025, 80
  • [50] IS RADIOTHERAPY AN OPTION FOR EARLY BREAST CANCERS WITH COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY?
    Daveau, Caroline
    Savignoni, Alexia
    Abrous-Anane, Soumya
    Pierga, Jean-Yves
    Reyal, Fabien
    Gautier, Chantal
    Kirova, Youlia M.
    Dendale, Remi
    Campana, Francois
    Fourquet, Alain
    Bollet, Marc A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1452 - 1459
12345